Cargando…

KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum

A recurrent de novo missense variant in KCNC1, encoding a voltage‐gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joohyun, Koko, Mahmoud, Hedrich, Ulrike B. S., Hermann, Andreas, Cremer, Kirsten, Haberlandt, Edda, Grimmel, Mona, Alhaddad, Bader, Beck‐Woedl, Stefanie, Harrer, Merle, Karall, Daniela, Kingelhoefer, Lisa, Tzschach, Andreas, Matthies, Lars C., Strom, Tim M., Ringelstein, Erich Bernd, Sturm, Marc, Engels, Hartmut, Wolff, Markus, Lerche, Holger, Haack, Tobias B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649617/
https://www.ncbi.nlm.nih.gov/pubmed/31353862
http://dx.doi.org/10.1002/acn3.50799
_version_ 1783438033261953024
author Park, Joohyun
Koko, Mahmoud
Hedrich, Ulrike B. S.
Hermann, Andreas
Cremer, Kirsten
Haberlandt, Edda
Grimmel, Mona
Alhaddad, Bader
Beck‐Woedl, Stefanie
Harrer, Merle
Karall, Daniela
Kingelhoefer, Lisa
Tzschach, Andreas
Matthies, Lars C.
Strom, Tim M.
Ringelstein, Erich Bernd
Sturm, Marc
Engels, Hartmut
Wolff, Markus
Lerche, Holger
Haack, Tobias B.
author_facet Park, Joohyun
Koko, Mahmoud
Hedrich, Ulrike B. S.
Hermann, Andreas
Cremer, Kirsten
Haberlandt, Edda
Grimmel, Mona
Alhaddad, Bader
Beck‐Woedl, Stefanie
Harrer, Merle
Karall, Daniela
Kingelhoefer, Lisa
Tzschach, Andreas
Matthies, Lars C.
Strom, Tim M.
Ringelstein, Erich Bernd
Sturm, Marc
Engels, Hartmut
Wolff, Markus
Lerche, Holger
Haack, Tobias B.
author_sort Park, Joohyun
collection PubMed
description A recurrent de novo missense variant in KCNC1, encoding a voltage‐gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 in five unrelated individuals causing different phenotypes featuring either isolated nonprogressive myoclonus (p.Cys208Tyr), intellectual disability (p.Thr399Met), or epilepsy with myoclonic, absence and generalized tonic‐clonic seizures, ataxia, and developmental delay (p.Ala421Val, three patients). Functional analyses demonstrated no measurable currents for all identified variants and dominant‐negative effects for p.Thr399Met and p.Ala421Val predicting neuronal disinhibition as the underlying disease mechanism.
format Online
Article
Text
id pubmed-6649617
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66496172019-07-31 KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum Park, Joohyun Koko, Mahmoud Hedrich, Ulrike B. S. Hermann, Andreas Cremer, Kirsten Haberlandt, Edda Grimmel, Mona Alhaddad, Bader Beck‐Woedl, Stefanie Harrer, Merle Karall, Daniela Kingelhoefer, Lisa Tzschach, Andreas Matthies, Lars C. Strom, Tim M. Ringelstein, Erich Bernd Sturm, Marc Engels, Hartmut Wolff, Markus Lerche, Holger Haack, Tobias B. Ann Clin Transl Neurol Brief Communications A recurrent de novo missense variant in KCNC1, encoding a voltage‐gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 in five unrelated individuals causing different phenotypes featuring either isolated nonprogressive myoclonus (p.Cys208Tyr), intellectual disability (p.Thr399Met), or epilepsy with myoclonic, absence and generalized tonic‐clonic seizures, ataxia, and developmental delay (p.Ala421Val, three patients). Functional analyses demonstrated no measurable currents for all identified variants and dominant‐negative effects for p.Thr399Met and p.Ala421Val predicting neuronal disinhibition as the underlying disease mechanism. John Wiley and Sons Inc. 2019-06-07 /pmc/articles/PMC6649617/ /pubmed/31353862 http://dx.doi.org/10.1002/acn3.50799 Text en © 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communications
Park, Joohyun
Koko, Mahmoud
Hedrich, Ulrike B. S.
Hermann, Andreas
Cremer, Kirsten
Haberlandt, Edda
Grimmel, Mona
Alhaddad, Bader
Beck‐Woedl, Stefanie
Harrer, Merle
Karall, Daniela
Kingelhoefer, Lisa
Tzschach, Andreas
Matthies, Lars C.
Strom, Tim M.
Ringelstein, Erich Bernd
Sturm, Marc
Engels, Hartmut
Wolff, Markus
Lerche, Holger
Haack, Tobias B.
KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title_full KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title_fullStr KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title_full_unstemmed KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title_short KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum
title_sort kcnc1‐related disorders: new de novo variants expand the phenotypic spectrum
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649617/
https://www.ncbi.nlm.nih.gov/pubmed/31353862
http://dx.doi.org/10.1002/acn3.50799
work_keys_str_mv AT parkjoohyun kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT kokomahmoud kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT hedrichulrikebs kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT hermannandreas kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT cremerkirsten kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT haberlandtedda kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT grimmelmona kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT alhaddadbader kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT beckwoedlstefanie kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT harrermerle kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT karalldaniela kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT kingelhoeferlisa kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT tzschachandreas kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT matthieslarsc kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT stromtimm kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT ringelsteinerichbernd kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT sturmmarc kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT engelshartmut kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT wolffmarkus kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT lercheholger kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum
AT haacktobiasb kcnc1relateddisordersnewdenovovariantsexpandthephenotypicspectrum